van den Besselaar, B. N. https://orcid.org/0009-0006-9787-088X
van Klaveren, D. https://orcid.org/0000-0002-2096-606X
Berzenji, D. https://orcid.org/0000-0002-5281-735X
Hoesseini, A. https://orcid.org/0000-0001-8049-6701
Jansen, J. C. https://orcid.org/0000-0002-3955-0152
Hardillo, J. A. https://orcid.org/0000-0001-5580-5613
Baatenburg de Jong, R. J. https://orcid.org/0000-0001-7236-264X
Offerman, M. P. J. https://orcid.org/0000-0001-8923-8354
Sewnaik, A.
Funding for this research was provided by:
KWF Kankerbestrijding (13528)
Article History
Received: 17 February 2025
Accepted: 12 May 2025
First Online: 24 May 2025
Declarations
:
: This study was approved by the ethics committee of the Erasmus Medical Center (MEC number: MEC-2016-751).
: The authors declare that they have no competing interests.
: An oral presentation of this article was held at the JOD Congress in Nijmegen, the Netherlands, on May 24, 2024. We received first prize for the best and most relevant presentation. An oral presentation of this article was held at the 7th CEORL-HNS Congress in Dublin, Ireland, on June 18, 2024.